Home › Regeneron Pharms Downgraded by Brean Murray
 

Keywords :   


Regeneron Pharms Downgraded by Brean Murray

2013-01-18 05:36:43| Biotech - Topix.net

A number of other firms have also recently commented on REGN. Analysts at Robert W. Baird raised their price target on shares of Regeneron Pharms from $176.00 to $205.00 in a research note to investors on Tuesday.

Tags: murray downgraded brean regeneron

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.09Hurricane Isaac Graphics
29.09Hurricane Isaac Forecast Discussion Number 13
29.09Tropical Storm Joyce Graphics
29.09Hurricane Isaac Wind Speed Probabilities Number 13
29.09Hurricane Isaac Public Advisory Number 13
29.09Summary for Hurricane Isaac (AT5/AL102024)
29.09Tropical Storm Joyce Wind Speed Probabilities Number 7
29.09Tropical Storm Joyce Forecast Discussion Number 7
More »